Crossmark

Investigation of the molecular mechanism of quercetin in inhibiting ankylosing spondylitis ossification via the bone morphogenetic protein/smad signaling pathway

Crossref DOI link: https://doi.org/10.1007/s00795-024-00417-9

Published Online: 2024-12-25

Published Print: 2025-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Zhenyu
License Information

Text and Data Mining valid from 2024-12-25

Version of Record valid from 2024-12-25
More Information

Article History

Received: 5 October 2024

Accepted: 27 November 2024

First Online: 25 December 2024

Declarations

:

: The authors declare that they have no conflict of interest.

: All experimental protocols were approved by Tianjin Medical University. All methods were carried out in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines.

: Not applicable.

Document is current

Any future updates will be listed below